NCT03706391View on ClinicalTrials.gov

Study of ALS Reversals 4: LifeTime Exposures

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Amyotrophic Lateral SclerosisProgressive Muscular AtrophyMotor Neuron Disease
Trial Locations (1)

27705

Duke ALS Clinic / DUSOM Dept of Neurology / DUHS, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National ALS Registry

UNKNOWN

collaborator

Centers for Disease Control and Prevention

FED

collaborator

Agency for Toxic Substances and Disease Registry

UNKNOWN

lead

Duke University

OTHER

NCT03706391 - Study of ALS Reversals 4: LifeTime Exposures | Biotech Hunter | Biotech Hunter